Showing results (81-90 of 100) with videos related to
Sort By:
Pageof 10
Molecular Therapy Oncolytics|February 22, 2021
Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer modelsThomas M McAusland, Jacob P van Vloten, Lisa A Santry, et al.Plos Pathogens|April 6, 2026
Adeno-associated virus delivery of anti-alpha toxin monoclonal antibodies confers protection against Staphylococcus aureus infectionsJosefien W Hommes, Madison E Hughes, Derek Cheung, et al.Journal for Immunotherapy of Cancer|March 17, 2022
Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancerJacob P van Vloten, Kathy Matuszewska, Mark A A Minow, et al.Molecular Therapy. Methods & Clinical Development|September 12, 2022
AAV-monoclonal antibody expression protects mice from Ebola virus without impeding the endogenous antibody response to heterologous challengeLaura P van Lieshout, Amira D Rghei, Wenguang Cao, et al.Gene Therapy|April 27, 2024
AAV-vectored expression of monospecific or bispecific monoclonal antibodies protects mice from lethal Pseudomonas aeruginosa pneumoniaJordyn A Lopes, Nicole E Garnier, Yanlong Pei, et al.Nature Communications|August 9, 2020
A lung tropic AAV vector improves survival in a mouse model of surfactant B deficiencyMartin H Kang, Laura P van Lieshout, Liqun Xu, et al.Gene Therapy|September 1, 2022
Adeno-associated virus mediated expression of monoclonal antibody MR191 protects mice against Marburg virus and provides long-term expression in sheepAmira D Rghei, Laura P van Lieshout, Wenguang Cao, et al.Journal of Virology|January 16, 2025
Vaccination against SARS-CoV-2 provides low-level cross-protection against common cold coronaviruses in mouse and non-human primate animal modelsMaedeh Naghibosadat, George Giorgi Babuadze, Yanlong Pei, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2022
Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1Gina M Cusimano, Ebony N Gary, Matthew R Bell, et al.Biomedicines|September 28, 2021
Safety and Tolerability of the Adeno-Associated Virus Vector, AAV6.2FF, Expressing a Monoclonal Antibody in Murine and Ovine Animal ModelsAmira D Rghei, Laura P van Lieshout, Benjamin M McLeod, et al.Pageof 10